tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
NextCure Inc (NXTC)
NASDAQ:NXTC
US Market
NXTC
NextCure
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

NextCure (NXTC) Stock News & Sentiment

Compare
296 Followers
Buy Rating Affirmed for NextCure: Promising LNCB74 Trial Progress and Competitive Edge in B7-H4 ADC Landscape
Premium
Ratings
Buy Rating Affirmed for NextCure: Promising LNCB74 Trial Progress and Competitive Edge in B7-H4 ADC Landscape
17d ago
NXTC
NextCure Reports Q1 2025 Results and Strategic Progress
Premium
Company Announcements
NextCure Reports Q1 2025 Results and Strategic Progress
17d ago
NXTC
NextCure Updates Presentation on LNCB74 Clinical Trial
Premium
Company Announcements
NextCure Updates Presentation on LNCB74 Clinical Trial
1M ago
8K
NXTC
Optimistic Buy Rating for NextCure Driven by Promising Developments in LNCB74 for Endometrial Cancer
Premium
Ratings
Optimistic Buy Rating for NextCure Driven by Promising Developments in LNCB74 for Endometrial Cancer
2M ago
NXTC
Nextcure Faces Delisting Risk Amid Nasdaq Compliance Struggles
Premium
Company Announcements
Nextcure Faces Delisting Risk Amid Nasdaq Compliance Struggles
2M ago
NXTC
NextCure Reports 2024 Financials and Strategic Progress
Premium
Company Announcements
NextCure Reports 2024 Financials and Strategic Progress
2M ago
NXTC
NextCure’s Promising Trajectory: Buy Rating Backed by Clinical Progress and Competitive Edge
Premium
Ratings
NextCure’s Promising Trajectory: Buy Rating Backed by Clinical Progress and Competitive Edge
2M ago
NXTC
More NXTC News >

NXTC News on the Web

H.C. Wainwright says competitor data builds optimism for NextCure's LNCB74
The Fly
Neutral
Nextcure Faces Delisting Risk Amid Nasdaq Compliance Struggles
TipRanks News
Neutral
NextCure Reports 2024 Financials and Strategic Progress
TipRanks News
Neutral
NextCure to Participate in the 36th Annual Piper Sandler Healthcare Conference
Yahoo Finance
Neutral
NextCure to Discuss Innovative Cancer Therapies
TipRanks News
Neutral
NextCure to Give Two Presentations at Society for Immunotherapy of Cancer Annual Meeting
Yahoo Finance
Neutral
NextCure Presented Results of the Phase 1b Study of NC410 in Combination with Pembrolizumab at ESMO 2024
Yahoo Finance
Neutral
Is NextCure In A Good Position To Deliver On Growth Plans?
Yahoo Finance
Neutral

News Score - Last 7 Days

Neutral
NXTC
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week59%
Sector Average54%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is NXTC’s Media Buzz Sentiment?
Currently, no data Available
What is NXTC’s weekly average amount of articles?
Currently, no data Available
What is NXTC’s News Sentiment?
59% of articles about NXTC were positive this week, compared to its sector average of 54%.
    Healthcare Stocks that are Trending in the News
    NPCENeuroPace
    AVDLAvadel Pharmaceuticals
    HALOHalozyme
    EXELExelixis
    9438MTI Ltd.
    Showing the stocks with the most bullish news sentiment over the past week

    Become an Expert with TipRanks Premium

    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis
    Subscribe NowSee Plans & Pricing